Journal of Lipid Research, Vol 38, 1085-1093, Copyright © 1997 by Lipid Research, Inc.

ARTICLES

Biochemical and biophysical characterization of human recombinant lecithin: cholesterol acyltransferase

L Jin, YP Lee and A Jonas
Department of Biochemistry, University of Illinois at Urbana-Champaign 61801, USA.

We established a Chinese hamster ovary cell line that constitutively expresses up to 5 mg/L of human recombinant lecithin: cholesterol acyltransferase (rLCAT). We purified the rLCAT to > 96% purity, and characterized it along with plasma LCAT (pLCAT) biochemically and biophysically. The recombinant enzyme is more heavily glycosylated and more heterogeneous in its carbohydrate content than the plasma enzyme, as revealed by differences in molecular weight and pI isoforms, determined by mass spectrometry and isoelectric focusing. Recombinant LCAT is half as active enzymatically as pLCAT. The difference in activity is due to differences in the catalytic rates rather than in the apparent K(m) values, suggesting that the binding of the rLCAT to interfaces is not altered by its different glycosylation pattern. Despite these differences, rLCAT has essentially the same intrinsic tryptophan fluorescence emission spectrum and far-UV CD spectrum as pLCAT, indicating that the tertiary and secondary structures of both enzyme forms are very similar. Both enzyme forms have a propensity to self-associate, and their multimers appear resistant to dissociation by SDS and dilution. The free energies of unfolding (delta G(H2O)) of rLCAT and pLCAT are 3.4 +/- 0.2 and 3.2 +/- 0.2 kcal/mol, respectively, as determined by guanidine hydrochloride denaturation monitored by fluorescence. These relatively low delta G(H2O) values support the notion that LCAT is capable of undergoing major conformational changes upon interaction with interfacial substrates.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Rossoni, M. Gomaraschi, F. Berti, C. R. Sirtori, G. Franceschini, and L. Calabresi Synthetic High-Density Lipoproteins Exert Cardioprotective Effects in Myocardial Ischemia/Reperfusion Injury J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 79 - 84. [Abstract] [Full Text] [PDF]

				D. Josse, C. Ebel, D. Stroebel, A. Fontaine, F. Borges, A. Echalier, D. Baud, F. Renault, M. le Maire, E. Chabrieres, et al. Oligomeric States of the Detergent-solubilized Human Serum Paraoxonase (PON1) J. Biol. Chem., August 30, 2002; 277(36): 33386 - 33397. [Abstract] [Full Text] [PDF]

				K.-H. Cho, D. M. Durbin, and A. Jonas Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements J. Lipid Res., March 1, 2001; 42(3): 379 - 389. [Abstract] [Full Text]

				J. W. Chisholm, A. K. Gebre, and J. S. Parks Characterization of C-terminal histidine-tagged human recombinant lecithin:cholesterol acyltransferase J. Lipid Res., August 1, 1999; 40(8): 1512 - 1519. [Abstract] [Full Text]

				S. Adimoolam, L. Jin, E. Grabbe, J.-J. Shieh, and A. Jonas Structural and Functional Properties of Two Mutants of Lecithin-Cholesterol Acyltransferase (T123I and N228K) J. Biol. Chem., December 4, 1998; 273(49): 32561 - 32567. [Abstract] [Full Text] [PDF]

				K.-H. Cho and A. Jonas A Key Point Mutation (V156E) Affects the Structure and Functions of Human Apolipoprotein A-I J. Biol. Chem., August 25, 2000; 275(35): 26821 - 26827. [Abstract] [Full Text] [PDF]

				J. Kosman and A. Jonas Deletion of Specific Glycan Chains Affects Differentially the Stability, Local Structures, and Activity of Lecithin-cholesterol Acyltransferase J. Biol. Chem., September 28, 2001; 276(40): 37230 - 37236. [Abstract] [Full Text] [PDF]